PubRank

Enrique F Schisterman

Author PubWeight™ 164.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004 14.00
2 The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006 6.69
3 The birth weight "paradox" uncovered? Am J Epidemiol 2006 4.38
4 Illustrating bias due to conditioning on a collider. Int J Epidemiol 2009 3.54
5 BioCycle study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol 2009 3.07
6 Quantification of collider-stratification bias and the birthweight paradox. Paediatr Perinat Epidemiol 2009 2.68
7 Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development--the LIFE Study. Paediatr Perinat Epidemiol 2011 2.50
8 Potential confounding by exposure history and prior outcomes: an example from perinatal epidemiology. Epidemiology 2007 2.45
9 The Youden Index and the optimal cut-point corrected for measurement error. Biom J 2005 2.26
10 Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol 2008 2.25
11 Stress reduces conception probabilities across the fertile window: evidence in support of relaxation. Fertil Steril 2010 2.02
12 Conditioning on intermediates in perinatal epidemiology. Epidemiology 2012 2.00
13 Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J 2008 1.95
14 Is it time for a meta-analysis? Hum Reprod Update 2008 1.79
15 Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res 2007 1.78
16 ROC curve analysis for biomarkers based on pooled assessments. Stat Med 2003 1.75
17 Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr 2009 1.69
18 An information criterion for marginal structural models. Stat Med 2012 1.65
19 Linear regression with an independent variable subject to a detection limit. Epidemiology 2010 1.61
20 Pooling biospecimens and limits of detection: effects on ROC curve analysis. Biostatistics 2006 1.58
21 Toxic trace metals and human oocytes during in vitro fertilization (IVF). Reprod Toxicol 2010 1.57
22 Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. Fertil Steril 2007 1.55
23 A time and place for causal inference methods in perinatal and paediatric epidemiology. Paediatr Perinat Epidemiol 2013 1.51
24 Will decreasing assisted reproduction technology costs improve utilization and outcomes among minority women? Fertil Steril 2010 1.51
25 Analysis of repeated pregnancy outcomes. Stat Methods Med Res 2006 1.48
26 "Toward a clearer definition of confounding" revisited with directed acyclic graphs. Am J Epidemiol 2012 1.48
27 Time at risk and intention-to-treat analyses: parallels and implications for inference. Epidemiology 2015 1.47
28 Receiver operating characteristic curve inference from a sample with a limit of detection. Am J Epidemiol 2006 1.46
29 Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect 2012 1.44
30 Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women. Am J Epidemiol 2010 1.44
31 Relative concentrations of organochlorines in adipose tissue and serum among reproductive age women. Environ Toxicol Pharmacol 2005 1.42
32 Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait. Obstet Gynecol 2016 1.40
33 Trying to avoid bias in case-control and case-cohort studies. Fertil Steril 2003 1.40
34 Estimating the odds ratio when exposure has a limit of detection. Int J Epidemiol 2009 1.39
35 Maximum likelihood ratio tests for comparing the discriminatory ability of biomarkers subject to limit of detection. Biometrics 2007 1.35
36 On linear combinations of biomarkers to improve diagnostic accuracy. Stat Med 2005 1.34
37 Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures. Stat Med 2008 1.31
38 From causal diagrams to birth weight-specific curves of infant mortality. Eur J Epidemiol 2008 1.30
39 Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab 2010 1.30
40 Heavy metals and couple fecundity, the LIFE Study. Chemosphere 2012 1.30
41 Invited commentary: composite outcomes as an attempt to escape from selection bias and related paradoxes. Am J Epidemiol 2013 1.27
42 Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004 1.25
43 Time-modified confounding. Am J Epidemiol 2009 1.24
44 Maternal serum polychlorinated biphenyl concentrations across critical windows of human development. Environ Health Perspect 2007 1.20
45 Circulating chemokine levels and miscarriage. Am J Epidemiol 2007 1.19
46 Efficient design and analysis of biospecimens with measurements subject to detection limit. Biom J 2006 1.17
47 A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab 2010 1.16
48 Pooling designs for outcomes under a Gaussian random effects model. Biometrics 2011 1.12
49 Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review. Am J Epidemiol 2013 1.11
50 Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the BioCycle Study. J Clin Endocrinol Metab 2011 1.08
51 Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers 2008 1.08
52 Realignment and multiple imputation of longitudinal data: an application to menstrual cycle data. Paediatr Perinat Epidemiol 2011 1.08
53 Treatment of batch in the detection, calibration, and quantification of immunoassays in large-scale epidemiologic studies. Epidemiology 2010 1.07
54 Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage. Fertil Steril 2007 1.07
55 The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod 2013 1.03
56 Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol 2012 1.02
57 Adherence to a Mediterranean diet and plasma concentrations of lipid peroxidation in premenopausal women. Am J Clin Nutr 2010 1.02
58 The effect of lipid adjustment on the analysis of environmental contaminants and the outcome of human health risks. Methods Mol Biol 2009 0.99
59 Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study. Am J Clin Nutr 2012 0.98
60 Generalized ROC curve inference for a biomarker subject to a limit of detection and measurement error. Stat Med 2009 0.98
61 Assays with lower detection limits: implications for epidemiological investigations. Paediatr Perinat Epidemiol 2008 0.97
62 Cadmium, lead, and mercury in relation to reproductive hormones and anovulation in premenopausal women. Environ Health Perspect 2011 0.97
63 The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. J Clin Endocrinol Metab 2012 0.97
64 A highly efficient design strategy for regression with outcome pooling. Stat Med 2014 0.95
65 The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome. Fertil Steril 2007 0.94
66 Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006 0.94
67 Glucose tolerance and risk of gestational diabetes mellitus in nulliparous women who smoke during pregnancy. Am J Epidemiol 2004 0.93
68 Regression for skewed biomarker outcomes subject to pooling. Biometrics 2014 0.93
69 Opening the black box of biomarker measurement error. Epidemiology 2010 0.93
70 Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol 2012 0.93
71 Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation. Hum Reprod 2010 0.93
72 A simulation study of finite-sample properties of marginal structural Cox proportional hazards models. Stat Med 2012 0.92
73 Nonparametric sequential evaluation of diagnostic biomarkers. Stat Med 2008 0.91
74 Higher urinary lignan concentrations in women but not men are positively associated with shorter time to pregnancy. J Nutr 2014 0.90
75 Whole grains are associated with serum concentrations of high sensitivity C-reactive protein among premenopausal women. J Nutr 2010 0.89
76 The impact of dietary folate intake on reproductive function in premenopausal women: a prospective cohort study. PLoS One 2012 0.88
77 Perceived stress and severity of perimenstrual symptoms: the BioCycle Study. J Womens Health (Larchmt) 2010 0.88
78 Pregnancy outcomes in smokers who develop pre-eclampsia. Paediatr Perinat Epidemiol 2005 0.88
79 Analytical and biological variation of F2-isoprostanes during the menstrual cycle. Clin Chem 2009 0.88
80 Racial differences in the association between sex hormone-binding globulin and adiposity in premenopausal women: the BioCycle study. Diabetes Care 2010 0.88
81 Changes in maternal serum chlorinated pesticide concentrations across critical windows of human reproduction and development. Environ Res 2008 0.87
82 Self-report of fruit and vegetable intake that meets the 5 a day recommendation is associated with reduced levels of oxidative stress biomarkers and increased levels of antioxidant defense in premenopausal women. J Acad Nutr Diet 2013 0.87
83 Ovarian function and cigarette smoking. Paediatr Perinat Epidemiol 2010 0.87
84 Validation of different instruments for caffeine measurement among premenopausal women in the BioCycle study. Am J Epidemiol 2013 0.87
85 A discussion of gene-gene and gene-environment interactions and longitudinal genetic analysis of complex traits. Stat Med 2012 0.86
86 Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth. J Womens Health (Larchmt) 2009 0.86
87 Monitoring quality control: can we get better data? Epidemiology 2008 0.85
88 ROC curve inference for best linear combination of two biomarkers subject to limits of detection. Biom J 2011 0.85
89 Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. J Clin Endocrinol Metab 2014 0.85
90 It's About Time: A Survival Approach to Gestational Weight Gain and Preterm Delivery. Epidemiology 2016 0.85
91 Selecting controls is not selecting "normals": design and analysis issues for studying the etiology of polycystic ovary syndrome. Fertil Steril 2006 0.84
92 Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod 2013 0.84
93 Low-dose aspirin and preterm birth: a randomized controlled trial. Obstet Gynecol 2015 0.84
94 Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype? J Clin Endocrinol Metab 2014 0.84
95 A gene-specific method for predicting hemophilia-causing point mutations. J Mol Biol 2013 0.83
96 Perfluorochemicals and human semen quality: the LIFE study. Environ Health Perspect 2014 0.83
97 Perceived stress, reproductive hormones, and ovulatory function: a prospective cohort study. Epidemiology 2015 0.82
98 Pancreatic beta-cell function and type 2 diabetes risk: quantify the causal effect using a Mendelian randomization approach based on meta-analyses. Hum Mol Genet 2012 0.82
99 Homogeneity tests of clustered diagnostic markers with applications to the BioCycle Study. Stat Med 2012 0.82
100 Multistage evaluation of measurement error in a reliability study. Biometrics 2006 0.82
101 Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix? Fertil Steril 2011 0.82
102 Gestational age and gestational age-at-delivery: cause, effect, or time-scale? Hum Reprod 2007 0.81
103 Factors Underlying the Temporal Increase in Maternal Mortality in the United States. Obstet Gynecol 2016 0.80
104 Energy-containing beverages: reproductive hormones and ovarian function in the BioCycle Study. Am J Clin Nutr 2013 0.80
105 Power and sample size calculation of comparative diagnostic accuracy studies with multiple correlated test results. Biom J 2005 0.80
106 Nonparametric ROC summary statistics for correlated diagnostic marker data. Stat Med 2012 0.80
107 Relation of blood cadmium, lead, and mercury levels to biomarkers of lipid peroxidation in premenopausal women. Am J Epidemiol 2012 0.79
108 Effect of daily fiber intake on luteinizing hormone levels in reproductive-aged women. Eur J Nutr 2011 0.79
109 Energy expenditure and plasma F2-isoprostanes across the menstrual cycle. Med Sci Sports Exerc 2011 0.78
110 Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses. Obstet Gynecol 2016 0.77
111 Habitual dietary isoflavone intake is associated with decreased C-reactive protein concentrations among healthy premenopausal women. J Nutr 2013 0.77
112 Semiparametric regression models for a right-skewed outcome subject to pooling. Am J Epidemiol 2015 0.77
113 Novel statistical methodology for analyzing longitudinal biomarker data. Stat Med 2012 0.77
114 Variations in lipid levels according to menstrual cycle phase: clinical implications. Clin Lipidol 2011 0.77
115 Serum Retinol and Carotenoids in Association with Biomarkers of Insulin Resistance among Premenopausal Women. ISRN Nutr 2013 0.77
116 Depressive symptoms and their relationship with endogenous reproductive hormones and sporadic anovulation in premenopausal women. Ann Epidemiol 2014 0.76
117 Kidney biomarkers associated with blood lead, mercury, and cadmium in premenopausal women: a prospective cohort study. J Toxicol Environ Health A 2015 0.76
118 Confidence interval estimation of the difference between paired AUCs based on combined biomarkers. J Stat Plan Inference 2009 0.75
119 Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss. J Clin Invest 2015 0.75
120 Usual dietary isoflavone intake and reproductive function across the menstrual cycle. Fertil Steril 2013 0.75
121 Measurement error! Communication between content experts and statisticians. Fertil Steril 2004 0.75
122 An additive selection of markers to improve diagnostic accuracy based on a discriminatory measure. Acad Radiol 2013 0.75
123 Multivariate normally distributed biomarkers subject to limits of detection and receiver operating characteristic curve inference. Acad Radiol 2013 0.75
124 Maternal plasma cellular fibronectin for early prediction of preeclampsia. Am J Obstet Gynecol 2003 0.75
125 Units of analysis-matched pairs, single patient, or cycles? Fertil Steril 2004 0.75
126 Outcome-related, auxiliary variable sampling designs for longitudinal binary data. Epidemiology 2017 0.75
127 In Reply. Obstet Gynecol 2016 0.75
128 Recruitment for longitudinal, randomised pregnancy trials initiated preconception: lessons from the effects of aspirin in gestation and reproduction trial. Paediatr Perinat Epidemiol 2015 0.75
129 Extending the case-control design to longitudinal data: stratied sampling based on repeated binary outcomes. Epidemiology 2017 0.75
130 Editorial: Reflections After a Year at the AJE. Am J Epidemiol 2020 0.75
131 New designs for new epidemiology. Epidemiology 2017 0.75
132 Reply to taguri and matsuyama. Stat Med 2013 0.75